A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

In May 2024, Novartis announced new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective ...

LSD is a relatively new drug, compared to many others. And its history has been influenced by some unlikely groups.

Operator Good morning and good afternoon, and welcome to the Novartis Q3 2024 results release conference call and live ...

The question that arises now is whether the false witnesses "Kelesi" and "Sarafis" will open their mouths & "snitch" on the ...

Butterfly Network is a digital health company pioneering accessible ultrasound technology through its handheld devices, with a mission to democratize high-quality imaging. The Butterfly iQ series has ...

Monte Rosa Therapeutics, Inc. secures $150M partnership with Novartis for immune treatments. Click for my updated look at ...

LONDON — It hasn’t even been a year since Pfizer closed its $43 billion acquisition of Seagen — one of the biggest biopharma deals in years — but David Epstein, who was CEO of Seagen, is back.

Fabhalta is the only oral alternative complement pathway inhibitor to selectively target the underlying cause of C3G, an ultra-rare kidney disease with no approved treatments 2-5 Novartis continues to ...

The previous update I wrote on Novartis was the Q2 earnings preview and I want to note that while my estimates on some of the key growth products were off, the general direction of my prediction ...

Supported by Novartis Pharma. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank the patients and their families; the investigators and ...

Supported by Novartis. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank all the patients for their participation in the ALIGN trial ...